Study | Setting (n) | n-3 PUFA-enriched lipid emulsion | Standard lipid emulsion | Clinical outcomes | Laboratory outcomes |
---|---|---|---|---|---|
ICU patients a ( n = 762) | |||||
Antebi 2004 [6] | Major surgery (20) | SO/MCT/OO/FOb | SO | ASTc, ALTc, CRP, alpha-T, TGc | |
Barbosa 2010 [7] | Sepsis (23) | SO/MCT/n-3 TGsd | SO/MCT | H LOS, ICU LOS, Mortality | CRP, EPA, DHA, AA, LTB4, AST, ALT, Bilirubin, OI, IL-6, PTT, Lac |
Berger 2008 [8] | Abdominal aortic aneurysm (24) | SO/MCT/n-3 TGsd | SO/MCT | Mortality, H LOS, ICU LOS | EPA, DHA, AA, alpha-T, CRP, TG |
Friesecke 2008 [9] | Critical medical (165) | SO + FOe | SO/MCT | Mortality, Infection rate, ICU LOS, Bleeding events | IL-6f TBU |
Heller 2004 [10] | Elective colorectal (44) | SO + FOe | SO | ICU LOS | AST, ALT, CRP, Bilirubin, PT (Quick), PTT, TBU |
Morlion 1996 [11] | Gastric carcinoma (20) | SO + FOe | SO | AA, EPA, DHA, LTB5, LTB4 | |
Piper 2009 [12] | Major abdominal or craniomaxillofacial surgery (44) | SO/MCT/OO/FOb | SO/OO | AST, ALT, TG | |
Roulet 1997 [13] | Elective oesophagectomy (19) | SO + FOe | SO | EPA, DHA, AA, BT | |
Sabater 2011 [14] | Acute respiratory distress syndrome (44) | SO/MCT/n-3 TGsd | SO | Mortality | LTB4 |
Wachtler 1997 [15] | Elective abdominal surgery (40) | SO/MCT/n-3 TGsd | SO/MCT | Infection rate, H LOS, ICU LOS | LTB4, LTB5, LTB ratio, IL-6f |
Wang 2008 [16] | Severe acute pancreatitis (40) | SO + FOe | SO | Mortality, Infection rate, H LOS, ICU LOS | EPA, CRP, OI |
Weiss 2002 [17] | Gastrointestinal surgery (23) | SO + FOe | SO | Mortality, Infection rate, H LOS, ICU LOS | IL-6g |
Wichmann 2007 [18] | Major intestinal surgery (256) | SO/MCT/n-3 TGsd | SO | Mortality, Infection rate, H LOS, ICU LOS | AST, Bilirubin, TG, CRP, LTB5, LTB ratio, alpha-T, EPA, PT (Quick), Cr |
Elective surgery, non-ICU patients ( n = 740) | |||||
Badia-Tahull 2010 [19] | Major gastrointestinal surgery (27) | SO + FOe | SO/OO | Mortality, H LOS, Infection rate | ALT, CRP, TBU, Cr, PlU |
Grimm 2006 [20] | Radical colorectal cancer resection (33) | SO/MCT/OO/FOb | SO | H LOSc | alpha-T, AA, EPA, DHA, LTB4, LTB5, LTB ratio |
Jiang 2010 [21] | Gastrointestinal malignancy (203) | SO + FOe | SO | H LOS, Infection rate, Bleeding events | IL-6, CrCl |
Klek 2005 [22] | Major abdominal surgery (58) | SO + FOe | SO/MCT | H LOS, Infection rate | ALT, AST, Cr, PlU |
Koeller 2003 [23] | Major abdominal surgery (30) | SO/MCT/n-3 TGsd | SO | LTB4, LTB5, LTB ratio | |
Liang 2008 [24] | Colorectal cancer (41) | SO + FOe | SO | Mortality, Infection rate, H LOS | IL-6 |
Linseisen 2000 [25] | Major abdominal surgery (33) | SO/MCT/n-3 TGscd | SO | alpha-T, AA, EPA, DHA | |
Makay 2011 [26] | Major gastric surgery (26) | SO + FOe | SO | Mortality, Infection rate, H LOS | AST, ALT, Cr, PlU; Lac |
Mertes 2006 [27] | Abdominal surgery (249) | SO/MCT/OO/FOb | SO | Mortality, H LOS | AST, ALT, TG, Bilirubin |
Senkal 2007 [28] | Major abdominal cancer (40) | SO/MCT/n-3 TGsd | SO/MCT | Infection rate | AA, EPA, DHA |